<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04017910</url>
  </required_header>
  <id_info>
    <org_study_id>2019-02</org_study_id>
    <secondary_id>2R44HL147423-04</secondary_id>
    <nct_id>NCT04017910</nct_id>
  </id_info>
  <brief_title>Automated 3D Ultrasound-based Surveillance of Arteriovenous Fistula Maturation for Post-operative Hemodialysis Patients</brief_title>
  <official_title>Automated 3D Ultrasound-based Surveillance of Arteriovenous Fistula Maturation for Post-operative Hemodialysis Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sonavex, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Heart, Lung, and Blood Institute (NHLBI)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Sonavex, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a two stage, prospective, multi-center study to evaluate the EchoMark and EchoSure&#xD;
      devices in patients undergoing peripheral arteriovenous fistula creation for hemodialysis&#xD;
      access.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is Stage 1 of a 2 stage protocol, targeting to enroll 60 patients in prospective, single&#xD;
      arm, non-randomized, multi-center observational study to record objective data in patients&#xD;
      undergoing upper extremity arteriovenous fistula construction with autologous tissue for the&#xD;
      purpose of eventual hemodialysis access, in whom the EchoMark is placed at the site of&#xD;
      vascular anastomosis. Follow-up visits include EchoSure and duplex imaging.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Conversion to IDE&#xD;
  </why_stopped>
  <start_date type="Actual">December 2, 2019</start_date>
  <completion_date type="Actual">May 12, 2021</completion_date>
  <primary_completion_date type="Actual">May 12, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Performance: Data Collection</measure>
    <time_frame>24 weeks</time_frame>
    <description>Data collection to verify accuracy</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Performance Endpoint</measure>
    <time_frame>24 Weeks</time_frame>
    <description>Data collection to understand the natural history of flow physiology in AV fistulas and classify the fistula that will fail.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Safety Endpoint</measure>
    <time_frame>24 Weeks</time_frame>
    <description>Number of Subjects with Freedom from Serious Adverse Events (SAEs) during the EchoMark implantation procedure and sub-sequent post-operative period.</description>
  </primary_outcome>
  <enrollment type="Actual">17</enrollment>
  <condition>Arteriovenous Fistula</condition>
  <condition>Arteriovenous Graft</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>EchoMark/EchoSure</intervention_name>
    <description>Each subject will have an EchoMark implanted at the time of arteriovenous fistula creation, and undergo EchoSure and duplex imaging follow-up.</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Adult patients undergoing arteriovenous fistula creation for hemodialysis access&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age &gt; 18 years&#xD;
&#xD;
          -  Patients presenting for upper extremity arteriovenous fistula construction with&#xD;
             autologous tissue for the purpose of eventual hemodialysis access where the surgeon&#xD;
             has selected EchoMark and EchoSure as the optimal method of vascular monitoring based&#xD;
             on clinical assessment and plan&#xD;
&#xD;
          -  Patient is able to sign informed consent and able to participate in all testing&#xD;
             associated with this clinical investigation&#xD;
&#xD;
          -  Women of childbearing potential have a negative pregnancy test&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Age &lt;18 years old&#xD;
&#xD;
          -  Patient unable to sign informed consent&#xD;
&#xD;
          -  Patient participating in another investigational device or pharmacological study&#xD;
&#xD;
          -  Prisoner or patient from vulnerable populations as defined in 45 CFR 46.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>University of Maryland School of Medicine</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21202</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Roanoke Vascular Access Center</name>
      <address>
        <city>Roanoke</city>
        <state>Virginia</state>
        <zip>24014</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>July 9, 2019</study_first_submitted>
  <study_first_submitted_qc>July 10, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">July 12, 2019</study_first_posted>
  <results_first_submitted>June 14, 2021</results_first_submitted>
  <results_first_submitted_qc>September 20, 2021</results_first_submitted_qc>
  <results_first_posted type="Actual">October 18, 2021</results_first_posted>
  <last_update_submitted>September 20, 2021</last_update_submitted>
  <last_update_submitted_qc>September 20, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 18, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Arteriovenous Fistula</mesh_term>
    <mesh_term>Fistula</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>May 19, 2019</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/10/NCT04017910/Prot_SAP_000.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Informed Consent Form</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>Yes</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>May 14, 2019</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/10/NCT04017910/ICF_001.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>EchoMark/EchoSure Stage 1</title>
          <description>EchoMark implantation at the time of fistula creation with scheduled follow up for EchoSure imaging of the fistula maturation process.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="17"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="17"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>There was 1 screen fail.</population>
      <group_list>
        <group group_id="B1">
          <title>EchoMark/EchoSure Stage 1</title>
          <description>EchoMark implantation at the time of fistula creation with scheduled follow up for EchoSure imaging of the fistula maturation process.</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="17"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="68" lower_limit="42" upper_limit="82"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Performance: Data Collection</title>
        <description>Data collection to verify accuracy</description>
        <time_frame>24 weeks</time_frame>
        <population>Data was not collected.</population>
        <group_list>
          <group group_id="O1">
            <title>EchoMark/EchoSure Stage 1</title>
            <description>EchoMark implantation at the time of fistula creation with scheduled follow up for EchoSure imaging of the fistula maturation process.</description>
          </group>
        </group_list>
        <measure>
          <title>Performance: Data Collection</title>
          <description>Data collection to verify accuracy</description>
          <population>Data was not collected.</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Performance Endpoint</title>
        <description>Data collection to understand the natural history of flow physiology in AV fistulas and classify the fistula that will fail.</description>
        <time_frame>24 Weeks</time_frame>
        <population>Data was not collected.</population>
        <group_list>
          <group group_id="O1">
            <title>EchoMark/EchoSure Stage 1</title>
            <description>EchoMark implantation at the time of fistula creation with scheduled follow up for EchoSure imaging of the fistula maturation process.</description>
          </group>
        </group_list>
        <measure>
          <title>Performance Endpoint</title>
          <description>Data collection to understand the natural history of flow physiology in AV fistulas and classify the fistula that will fail.</description>
          <population>Data was not collected.</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Safety Endpoint</title>
        <description>Number of Subjects with Freedom from Serious Adverse Events (SAEs) during the EchoMark implantation procedure and sub-sequent post-operative period.</description>
        <time_frame>24 Weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>EchoMark/EchoSure Stage 1</title>
            <description>EchoMark implantation at the time of fistula creation with scheduled follow up for EchoSure imaging of the fistula maturation process.</description>
          </group>
        </group_list>
        <measure>
          <title>Safety Endpoint</title>
          <description>Number of Subjects with Freedom from Serious Adverse Events (SAEs) during the EchoMark implantation procedure and sub-sequent post-operative period.</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="17"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>1 year</time_frame>
      <group_list>
        <group group_id="E1">
          <title>EchoMark/EchoSure Stage 1</title>
          <description>EchoMark implantation at the time of fistula creation with scheduled follow up for EchoSure imaging of the fistula maturation process.</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="17"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="17"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Seroma / Possible Infection</sub_title>
                <description>Possibly Device Related</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="17"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="17"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>Edema</sub_title>
                <description>Not Device Related</description>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="17"/>
              </event>
              <event>
                <sub_title>Seroma</sub_title>
                <description>Not Device Related</description>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="17"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>This was designed as 2 Stage Study. Subjects were only enrolled into Stage 1 and the study has been terminated&#xD;
One immunocompromised transplant subject experienced a potential local wound infection and the event was deemed to be possibly device related.&#xD;
Two subjects passed away during the study. One was deemed not to be in relation to the study device. The second was deemed possibly related due to a sudden death within the thirty-day postoperative window.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Katy Feeny</name_or_title>
      <organization>Sonavex</organization>
      <phone>443-862-2024</phone>
      <email>kfeeny@sonavex.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

